Osmoregulatory substance accumulation

Osmoregulatory substance accumulation is a critical physiological process where cells gather organic osmolytes—such as sorbitol, betaine, taurine, and myo-inositol—to counteract external osmotic pressure and maintain cell volume (Burg et al., 2007). This process is largely orchestrated by the transcription factor NFAT5 (Tonicity-responsive enhancer binding protein), which upregulates the expression of specific transporters and enzymes in response to hypertonicity (Miyakawa et al., 1999). In the context of pathology, the excessive accumulation of sorbitol via the polyol pathway is a hallmark of diabetic complications, where it induces oxidative stress and cellular damage in the nerves and kidneys (Brownlee, 2001). Conversely, in conditions like dry eye disease, the depletion of these substances leads to hyperosmolar stress, which can be treated using exogenous osmoprotectants to restore ocular surface homeostasis (Willcox et al., 2017). Because this term describes a complex biological outcome involving multiple proteins rather than a single molecular entity, it is categorized as a biological process rather than a discrete therapeutic target.

Other names

Organic osmolyte accumulationCompatible solute accumulationCellular osmoregulationOsmoprotectant accumulationIntracellular osmolyte regulation

Modulation of intracellular solute concentrations through the inhibition of biosynthetic enzymes (e.g., aldose reductase) or the supplementation of compatible solutes to stabilize cellular membranes and prevent osmotic lysis.